Device Sutures

Ethibond Excel

Payments companies reported to CMS as associated with Ethibond Excel. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$317Kassociated payments (2023-2025)
42clinicians with associated payments
4companies reporting

By year

2023 $59K
2024 $180K
2025 $79K

Payments reported as associated with Ethibond Excel, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $308K
Vascular Surgery $8,909
Physician Assistant $169
Surgery $157
Surgical $114
Plastic Surgery $57.88

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ethibond Excel

These are the largest totals companies reported as associated with Ethibond Excel. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Arthur Martella Rochester, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $198,761.75
Bo Yang Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $45,498.56
Kourosh Asgarian Neptune, NJ Thoracic Surgery (Cardiothoracic Vascular Surgery) $34,875.00
Jorge Salazar Houston, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,992.50
Sagar Gandhi Greenville, SC Vascular Surgery $8,167.50
Eugene Grossi New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,470.00
Isaac George New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,166.25
Tsuyoshi Kaneko Saint Louis, MO Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,020.00
Nahush Mokadam Columbus, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,800.00
Joseph Blas Greenville, SC Vascular Surgery $605.00

Prescribed Ethibond Excel?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.